Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Total Liabilities: 2015-2025

Historic Total Liabilities for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $534.0 million.

  • HUTCHMED (China)'s Total Liabilities rose 4.95% to $534.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 billion, marking a year-over-year increase of 17.09%. This contributed to the annual value of $392.6 million for FY2022, which is 17.84% up from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s Total Liabilities is $534.0 million, which was up 4.95% from $508.9 million recorded in Q2 2024.
  • In the past 5 years, HUTCHMED (China)'s Total Liabilities ranged from a high of $534.0 million in Q2 2025 and a low of $228.7 million during Q1 2021.
  • Its 3-year average for Total Liabilities is $513.4 million, with a median of $508.9 million in 2024.
  • Data for HUTCHMED (China)'s Total Liabilities shows a peak YoY skyrocketed of 63.51% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Total Liabilities stood at $333.1 million in 2021, then rose by 17.84% to $392.6 million in 2022, then skyrocketed by 45.26% to $497.5 million in 2023, then rose by 2.29% to $508.9 million in 2024, then increased by 4.95% to $534.0 million in 2025.
  • Its last three reported values are $534.0 million in Q2 2025, $508.9 million for Q2 2024, and $497.5 million during Q2 2023.